Allansmith M R, Baird R S, Barney N P, Ross R N, Bloch K J
Eye Research Institute, Boston, Mass.
Ophthalmic Res. 1990;22(3):137-43. doi: 10.1159/000267014.
We studied the effect of one application of compound 48/80 to the conjunctiva of the rat on the response to a subsequent challenge. Rats treated once showed conjunctival edema and marked degranulation of conjunctival mast cells. A second exposure to compound 48/80, applied after an interval of 24 h, produced slight clinical effects but had marked effects on conjunctival mast cells. Approximately 90% of the mast cells could no longer be observed by light microscopy. As the interval between initial challenge and rechallenge was increased, the clinical response returned, mast cells were again observable in normal numbers, and the extent of degranulation returned to approximately 50%. After an interval of 7 days, rats responded clinically as they had to the first application of compound 48/80. Although the number of mast cells in the conjunctiva was normal and extensive degranulation occurred, exocytosis was not observed. Thus some effects of the first application of compound 48/80 persisted for at least 1 week. Whether the effects observed depend upon the continued presence of compound 48/80 in the mast cell or granule membrane remains to be determined.
我们研究了将化合物48/80单次应用于大鼠结膜对后续刺激反应的影响。单次处理的大鼠出现结膜水肿和结膜肥大细胞明显脱颗粒。在间隔24小时后再次暴露于化合物48/80,产生轻微的临床效应,但对结膜肥大细胞有显著影响。通过光学显微镜观察,约90%的肥大细胞不再可见。随着初次刺激与再次刺激之间的间隔时间增加,临床反应恢复,肥大细胞数量再次恢复正常,脱颗粒程度恢复至约50%。间隔7天后,大鼠的临床反应与首次应用化合物48/80时相同。尽管结膜中肥大细胞数量正常且发生广泛脱颗粒,但未观察到胞吐作用。因此,首次应用化合物48/80的某些效应至少持续1周。观察到的这些效应是否取决于化合物48/80在肥大细胞或颗粒膜中的持续存在仍有待确定。